OPTImal PHARMacological Therapy for Patients With Heart Failure: The OPTIPHARM-HF Registry
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Prospective, observational, multicenter, national study of adult patients with HF to assess prescription and adherence to evidence-based Guideline-Directed Medical Therapy (GDMT) in patients with Heart Failure (HF).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients ≥ 18 years old
• Signed patient informed consent form (ICF)
• Diagnosis of chronic or acute decompensated HF according to ESC guidelines and the universal definition of HF.
• Receiving at least one drug for management of HF at study enrollment (including diuretics, β-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, aldosterone antagonists).
Locations
Other Locations
Italy
ASST Spedali Civili
RECRUITING
Brescia
Contact Information
Primary
Cristina Gussago
studiclinici.brescia@gmail.com
030 3996927
Time Frame
Start Date: 2022-07-18
Estimated Completion Date: 2025-10-01
Participants
Target number of participants: 2000
Related Therapeutic Areas
Sponsors
Collaborators: IRCCS Policlinico S. Donato, A.O. Ospedale Papa Giovanni XXIII, Azienda Ospedaliera S. Maria della Misericordia, Azienda Ospedaliera Universitaria Senese, IRCCS Humanitas, Rozzano, Fondazione IRCCS Policlinico San Matteo di Pavia, Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy, ASST Santi Paolo e Carlo, Ospedali Riuniti di Foggia, ASU Giuliano Isontina, Trieste, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, IRCCS Ospedale San Raffaele, Ospedale Policlinico San Martino, A.O.U. Città della Salute e della Scienza, Centro Cardiologico Monzino
Leads: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia